Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on June 30, 2025
New 2025 Summer Guide Empowers Seniors to Stay Independent as Mobility Equipment Innovation Surges Nationwide
EIN Presswire
·
June 30, 2025
2025 summer guide highlights expert strategies, upgraded mobility tools, and new solutions to help seniors stay active, safe, and socially engaged outdoors. MIAMI, FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- With record-setting heat waves, …
Long-Term Psychological Effects of PFAS Exposure and Chronic Illness
EIN Presswire
·
June 30, 2025
Emerging research links PFAS exposure to mental distress—Legal Claim Assistant urges support for affected communities and families. MIAMI, FLORIDA, FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- As scientific understanding of PFAS-related health …
Ciro Manufacturing Celebrates 25 Years of Excellence in Life Sciences and Precision Plastics
EIN Presswire
·
June 30, 2025
DEERFIELD BEACH, FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Ciro Manufacturing Corporation, a leading U.S.-based provider of plastic injection molding, reagent formulation, and diagnostic kit production, proudly celebrates 25 years of …
IV Therapy Academy Announces Full-Tuition Scholarship for the Business Accelerator Program
EIN Presswire
·
June 30, 2025
IV Therapy Academy is Launching a New Annual Full-Tuition Scholarship for the Business Accelerator Training FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- IV Therapy Academy is thrilled to announce the launch of a new annual scholarship for the …
Inga Ellzey Billing Companies to Exhibit at 2025 AAD Innovation Academy
EIN Presswire
·
June 30, 2025
Cut Through the Billing Chaos: Real Solutions for Real Dermatology Practices CASSELBERRY, FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Inga Ellzey Billing Companies will be an exhibitor at the 2025 AAD Innovation Academy, taking place July 10– …
Brightside ABA Expands Riverview Clinic to Serve More Local Families Throughout Hillsborough County
EIN Presswire
·
June 30, 2025
Serving the Deserving Families and Children Diagnosed with Autism with a Large Scaled Expansion of our Riverview, FL Clinic TAMPA, FL, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Brightside ABA is proud to announce the expansion of its Riverview, …
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
GlobeNewswire
·
June 30, 2025
SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
GlobeNewswire
·
June 30, 2025
TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and …
Thought Leadership & Innovation Foundation Releases White Paper Showcasing Model for Non-Profit Collaboration to Improve Outcomes for Chronic Disease Communities
GlobeNewswire
·
June 30, 2025
MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- The Thought Leadership …
Avicanna Announces Results of Annual General Meeting
GlobeNewswire
·
June 30, 2025
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
GlobeNewswire
·
June 30, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), …
Academy Announces Host, Executive Producer and Author Andy Cohen as 2025 FNCE® Closing Keynote Speaker
GlobeNewswire
·
June 30, 2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Food and nutrition experts from around the world will gather in Nashville, Tenn., October 11-14, for the Academy of Nutrition and Dietetics' 2025 Food …
TerrAscend Announces Strategic Exit from Michigan Market
GlobeNewswire
·
June 30, 2025
Net Proceeds from divestitures to pay down Company debt Enables concentrated growth and improved profitability in core markets TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend”) (TSX: TSND, OTCQX: TSNDF), a leading North American …
Aptose Announces Deferral of Interest Payment
GlobeNewswire
·
June 30, 2025
SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 30, 2025
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported today that Pyxis Oncology’s …
PetVivo Reports Fiscal 2025 Results
GlobeNewswire
·
June 30, 2025
MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative medical therapeutics for equines and …
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
GlobeNewswire
·
June 30, 2025
CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider …
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
·
June 30, 2025
Boca Raton, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, (the …
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 30, 2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has …
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
GlobeNewswire
·
June 30, 2025
As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all participants currently enrolled is now …